corporate officers and executive leadership

https://www.novocure.com/wp-content/uploads/2021/12/06_cordova-1024x640.jpg

Ashley Cordova
Chief Executive Officer

Ashley Cordova is the Chief Executive Officer (CEO) of Novocure since January 2025. She previously served as our Chief Financial Officer from 2020 to 2024.

learn more
https://www.novocure.com/wp-content/uploads/2022/04/Barak-Ben-Arye-1024x683.jpg

Barak Ben-Arye
General Counsel

Barak Ben-Arye has been General Counsel of Novocure since April 2022. He previously served as our Vice President, EMEA Counsel since June 2019.

learn more
https://www.novocure.com/wp-content/uploads/2024/11/cb_1200-1024x640.jpeg

Christoph Brackmann
Chief Financial Officer

Christoph Brackmann is the Chief Financial Officer (CFO) of Novocure since January 2025. He previously served as Senior Vice President of Finance at Moderna from 2019 to 2024.

learn more
https://www.novocure.com/wp-content/uploads/2021/12/01_doyle-1024x640.jpg

William F. Doyle
Executive Chairman

William Doyle has served as the Executive Chairman of Novocure since 2016, as Chairman of the Board since 2009 and as a member of our Board of Directors since 2004.

learn more
https://www.novocure.com/wp-content/uploads/2020/09/Frank-Leonard-headshot3-e1703107625460-1024x640.png

Frank Leonard
Executive Vice President and President, Novocure Oncology

Frank Leonard is the Executive Vice President and President, Novocure Oncology since January 2024. Previously, he served as President, CNS Cancers U.S. from 2022 to 2023, and as our Chief Development Officer from 2020 to 2022.

learn more
https://www.novocure.com/wp-content/uploads/2024/01/Nicolas-Leupin-e1710530458787-1024x640.png

Nicolas Leupin M.D., Ph.D.
Chief Medical Officer

Nicolas Leupin is the Chief Medical Officer (CMO) of Novocure since January 2024. He previously served as the Chief Medical Officer at Molecular Partners, a clinical-stage biopharmaceutical company.

learn more
https://www.novocure.com/wp-content/uploads/2021/12/03_palti-1024x640.jpg

Yoram Palti, M.D., Ph.D.
Founder

Professor Yoram Palti founded Novocure in 2000, has been our Chief Technology Officer, serving as a consultant, since 2000 and was a director of Novocure from 2002 to 2018.

https://www.novocure.com/wp-content/uploads/2024/09/02_paravathsu-1024x640.jpg

Mukund Paravasthu
Chief Operating Officer

Mukund Paravasthu is the Chief Operating Officer (COO) of Novocure since October 2024. He previously served as Senior Vice President of Product Development since 2022.

learn more
https://www.novocure.com/wp-content/uploads/2023/09/mp-1024x640.jpg

Michael Puri
Chief Human Resources Officer

Michael Puri has served as Chief Human Resources Officer (CHRO) of Novocure since September 2023. He previously served as Vice President, HR Integration lead at CSL Limited, following the company’s acquisition of Vifor Pharma, where he served as Chief Human Resources Officer from 2015 to 2022.

learn more
https://www.novocure.com/wp-content/uploads/2021/12/11_weinberg-1024x640.jpg

Uri Weinberg, M.D., Ph.D.
Chief Innovation Officer

Dr. Uri Weinberg is the Chief Innovation Officer at Novocure. He previously served as our Chief Science Officer. Dr. Weinberg joined Novocure in 2008.

learn more
https://www.novocure.com/wp-content/uploads/2024/03/yp_8_5_02-1024x640.jpg

our history

Novocure was founded in 2000 by Prof. Yoram Palti, who discovered the effects of TTFields on cancer cells.

discover our history